Order Article Reprints

Ureshino H, Takeda Y, Kamachi K, Ono T, Iriyama N, Ohtsuka E, Sakaida E, Kimura S. A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment. Clinics and Practice. 2024; 14(4):1216-1224. https://doi.org/10.3390/clinpract14040097

Ureshino, Hiroshi, Yusuke Takeda, Kazuharu Kamachi, Takaaki Ono, Noriyoshi Iriyama, Eiichi Ohtsuka, Emiko Sakaida, and Shinya Kimura. 2024. "A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment" Clinics and Practice 14, no. 4: 1216-1224. https://doi.org/10.3390/clinpract14040097

Ureshino, H., Takeda, Y., Kamachi, K., Ono, T., Iriyama, N., Ohtsuka, E., Sakaida, E., & Kimura, S. (2024). A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment. Clinics and Practice, 14(4), 1216-1224. https://doi.org/10.3390/clinpract14040097